Losartan Potassium Active Pharmaceutical Ingredient (API) Market Report 2026

Losartan Potassium Active Pharmaceutical Ingredient (API) Market Overview

• Losartan Potassium Active Pharmaceutical Ingredient (API) market size has reached to $1.85 billion in 2025 • Expected to grow to $2.54 billion in 2030 at a compound annual growth rate (CAGR) of 6.5% • Growth Driver: Growing Prevalence Of Hypertension Is Fueling The Growth Of The Market Due To Increasing Incidence And Health Risks Associated With High Blood Pressure • Market Trend: Development In Ready-To-Use Losartan Potassium Oral Suspension Enhances Patient Compliance And Dosing Precision • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Losartan Potassium Active Pharmaceutical Ingredient (API) Market?

Losartan potassium active pharmaceutical ingredient (API) refers to the pure, active compound used in the formulation of losartan-based medications to treat high blood pressure and safeguard kidney function. It primarily manages high blood pressure, reduces the risk of heart attacks, and protects kidney function in diabetic patients. The main product types of losartan potassium active pharmaceutical ingredient (API) are tablets, capsules, and others. Tablets are the most common oral form of losartan potassium, favored for their ease of use, affordability, and accurate dosing in managing hypertension. It is manufactured through various production methods such as synthetic route, biotechnological process, continuous flow production, and is distributed through several distribution channels, including online pharmacies, hospital pharmacies, retail pharmacies, and others. It is applicable in various applications such as hypertension, heart failure, chronic kidney diseases, and others, and is used by several end-users, including hospitals, clinics, home care settings, and pharmaceutical companies.

What Is The Losartan Potassium Active Pharmaceutical Ingredient (API) Market Growth Forecast?

The losartan potassium active pharmaceutical ingredient (api) market size is expected to see strong growth in the next few years. It will grow to $2.54 billion in 2030 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to growth in cardiovascular disease burden, increasing demand from emerging markets, advancements in api manufacturing technologies, rising focus on sustainable pharmaceutical production, expansion of chronic kidney disease treatment applications. Major trends in the forecast period include increasing demand for generic losartan formulations, growing adoption of continuous flow api manufacturing, rising focus on cost-efficient antihypertensive apis, expansion of losartan api use in combination therapies, increasing emphasis on regulatory-compliant api production.

Global Losartan Potassium Active Pharmaceutical Ingredient (API) Market Segmentation

1) By Product Type: Tablet, Capsule, Other Product Types 2) By Production Method: Synthetic Route, Continuous Flow Production 3) By Distribution Channel: Online Pharmacies, Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels 4) By Application: Hypertension, Heart Failure, Chronic Kidney Diseases, Other Applications 5) By End-User: Hospitals, Clinics, Pharmaceutical Companies Subsegments: 1) By Tablet: Immediate-Release Tablets, Extended-Release Tablets, Film-Coated Tablets, Orally Disintegrating Tablets 2) By Capsule: Hard Gelatin Capsules, Modified-Release Capsules 3) By Other Product Types: Bulk Active Pharmaceutical Ingredient (API) Powder, Granules For Suspension, Pre-Formulated Intermediates

What Is The Driver Of The Losartan Potassium Active Pharmaceutical Ingredient (API) Market?

The growing prevalence of hypertension is expected to propel the growth of the losartan potassium active pharmaceutical ingredient (API) market going forward. Hypertension is a condition marked by persistently high blood pressure, which can raise the likelihood of heart disease, stroke, and other severe health complications. The growing incidence of hypertension is linked to diets rich in salt and processed foods, which lead to fluid retention and increased heart strain. Losartan potassium helps control hypertension by blocking angiotensin II, a hormone that narrows blood vessels. It helps relax and widen the vessels, lowering blood pressure and easing the heart's workload. For instance, in September 2025, according to the World Health Organization (WHO), a Geneva, Switzerland-based global health authority, about 1.4 billion adults aged 30–79 years had hypertension in 2024 compared with approximately 1.3 billion adults in 2022. Therefore, the growing prevalence of hypertension is driving the growth of the losartan potassium active pharmaceutical ingredient (API) industry.

Key Players In The Global Losartan Potassium Active Pharmaceutical Ingredient (API) Market

Major companies operating in the losartan potassium active pharmaceutical ingredient (api) market are Teva Pharmaceutical Industries Ltd, Sun Pharmaceutical Industries Ltd, Aurobindo Pharma Ltd, Dr. Reddy’s Laboratories, Cadila Pharmaceuticals Ltd, Lupin Ltd, Zydus Lifesciences Ltd, Alkem Laboratories Ltd, IPCA Laboratories Ltd, Alembic Pharmaceuticals Ltd, Granules India Limited, Vasudha Pharma Chem Ltd, IOL Chemicals and Pharmaceuticals Limited, Unichem Laboratories Ltd, Global Pharma Tek, Hetero Drugs Ltd, Manus Aktteva Biopharma LLP, Wellona Pharma, Atom pharma, Sinoway Industrial Co. Ltd, Cerata Pharmaceuticals LLP

Global Losartan Potassium Active Pharmaceutical Ingredient (API) Market Trends and Insights

Major companies operating in the losartan potassium active pharmaceutical ingredient (API) market are focusing on developing innovative products and getting approvals, such as losartan potassium oral suspension, to enhance patient compliance and expand therapeutic applications. Losartan potassium oral suspension is a liquid form of medication losartan potassium, intended for individuals who struggle with swallowing tablets. For instance, in March 2025, Scienture Holdings Inc., a US-based biopharmaceutical company, received Food and Drug Administration (FDA) approval for Arbli. Arbli is a ready-to-use liquid formulation for hypertension, stroke risk reduction in hypertensive patients with left ventricular hypertrophy, and diabetic nephropathy in type 2 diabetes patients. It offers precise dosing without compounding and is available in a 165 mL peppermint-flavored suspension (10 mg/mL) with an 18-month shelf life at room temperature.

What Are Latest Mergers And Acquisitions In The Losartan Potassium Active Pharmaceutical Ingredient (API) Market?

In April 2025, Scienture Holdings Inc., a US-based pharmaceutical company, partnered with Saptalis Pharmaceuticals LLC. The partnership aims to manufacture Arbli (losartan potassium) Oral Suspension, 10 mg/mL, including warehousing and distribution agreements, to ensure market readiness for the first Food and Drug Administration (FDA)-approved ready-to-use oral liquid losartan, addressing unmet needs in hypertension treatment. Saptalis Pharmaceuticals LLC is a US-based pharmaceutical company specializing in developing and distributing losartan potassium formulations.

Regional Insights

North America was the largest region in the losartan potassium API market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Losartan Potassium Active Pharmaceutical Ingredient (API) Market?

The losartan potassium active pharmaceutical ingredient (API) market consists of sales of bulk powder, granules, injectable concentrates, and pre-formulated intermediates. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Losartan Potassium Active Pharmaceutical Ingredient (API) Market Report 2026?

The losartan potassium active pharmaceutical ingredient (api) market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the losartan potassium active pharmaceutical ingredient (api) industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.